ArticleBMC primary care2026
General practitioners' involvement in oncological aftercare (ACTION): a study protocol for a mixed-methods study.
Article in BMC primary care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundThe growing number of cancer survivors in Germany necessitates sustainable, interdisciplinary aftercare. General practitioners (GPs) are well-positioned to provide long-term, trust-based support, including early detection of recurrences and late effects. However, evidence on the level of GP involvement in oncological aftercare, on interdisciplinary aftercare models involving GPs and specialists, and on associated barriers and facilitators remains limited.
methodsThe project "general practitioners' involvement in oncological aftercare" (ACTION; funded by the German Cancer Aid; grant number 70116960) will employ a mixed-methods approach across two phases. In phase 1, experiences with GPs involvement in oncological aftercare will be examined. Therefore, routine data from the AOK Lower Saxony and the Lower Saxony Cancer Registry will be analysed retrospectively (WP1a), supplemented by surveys of GPs (WP1b) and oncologists (WP1c), and qualitative interviews with patients (WP1d). Phase 2 will then build on the results from phase 1 to develop and agree on recommendations for GP involvement in oncological aftercare. An expert workshop will aim to develop structured recommendations for enhanced GP involvement (WP2a), which are refined via a Delphi consensus process (WP2b). DISCUSSION: The ACTION project will generate new insights into the involvement of GPs in oncological aftercare and contribute to adequately addressing future challenges in patient care. It will stimulate the empirically supported development and implementation of interdisciplinary aftercare models in clinical practice and has thus the chance to improve the long-term care of cancer survivors in Germany.
trial registrationThe study was registered with the German Clinical Trials Register (Deutsches Register Klinischer Studien; DRKS00040034; date of registration: 11 May 2026).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.